Anti-Kickback Safe Harbor Provisions: HHS and OIG Changes to Regulate and Restrict Remuneration

New Safe Harbor for POS Price Reductions on Prescription Drugs and PBM Service Fees, Loss of Safe Harbor for Drug Rebates

Recording of a 90-minute CLE webinar with Q&A

Conducted on Tuesday, March 19, 2019

Recorded event now available

or call 1-800-926-7926
Course Materials

This CLE course will guide healthcare counsel on the changes to Anti-Kickback Statute (AKS) safe harbors. The panel will examine the removal of protection for rebates to pharmacy benefit managers (PBMs) and the new safe harbors for point-of-sale discounts and service fees. The panel will discuss how stakeholders in the healthcare industry can take advantage of the changes and ensure compliance.


The U.S. Department of Health and Human Services (HHS) and the Office of Inspector General (OIG) issued proposed regulations that amend the safe harbor provisions under the federal Anti-Kickback Statute (AKS) to exclude pharmaceutical manufacturer discounts to PBMs and Medicare Part D and Medicaid managed care plans from safe harbor protection.

Such rebates to health plan sponsors and PBMs have been a central piece in drug distribution and reimbursement in the U.S. These changes could dramatically impact consumers and supply chain stakeholders.

The amendments also create new safe harbor provisions for point-of-sale discounts on prescription drugs as well as PBM service fees. The point-of-sale-discounts safe harbor requires the discount to be set in advance and applied at the point of sale. A rebate may be involved only if the discount is given to the pharmacy through a chargeback.

OIG is requesting and accepting public comments until Apr. 8, 2019. The proposed rule would go into effect on Jan. 1, 2020.

Listen as our authoritative panel examines the proposed amendments to AKS safe harbor protection. The panel will explore the removal of protection for rebates to PBMs and health plans and the new safe harbors for point-of-sale discounts and service fees. The panel will discuss how those in the healthcare industry will be impacted and can take advantage of the changes and ensure compliance.



  1. Overview and background of proposed rulemaking
  2. Removal of safe harbor protections for PBM and health plan rebates
  3. New safe harbors
    1. Point-of-sale discounts
    2. PBM service fees
  4. Impact of the changes
  5. What stakeholders in the healthcare industry and counsel need to do


The panel will review these and other key issues:

  • What is the impact of the changes on drug distribution and reimbursement?
  • What is the scope of application of the proposed changes?
  • What must stakeholders in the healthcare industry do to ensure compliance with the safe harbor changes?


Mikel, Clinton
Clinton Mikel

The Health Law Partners

Mr. Mikel has practiced in almost all areas of healthcare law but has focused his practice on compliance with federal...  |  Read More

Oppenheim, Charles
Charles B. Oppenheim

Hooper Lundy & Bookman

Mr. Oppenheim’s practice includes all aspects of transactional, operational and regulatory healthcare law,...  |  Read More

Wright, Jill
Jill S. Wright

Special Counsel
Foley & Lardner

Ms. Wright’s practice focuses on healthcare fraud and abuse and compliance issues, including the federal...  |  Read More

Access Anytime, Anywhere

Strafford will process CLE credit for one person on each recording. All formats include course handouts.

To find out which recorded format will provide the best CLE option, select your state:

CLE On-Demand Video